Available evidence, primarily from case reports and post-marketing surveillance, suggests that gastrointestinal symptoms related to GLP-1 receptor agonists are typically reversible upon discontinuation of the medication, though the timeframe and extent of recovery can vary considerably between individuals
Berkovic MC, Virovic-Jukic L, Bilic-Curcic I, Mrzljak A
Izervay is a PEGylated oligonucleotide that works by targeting and disabling the C5 complement protein, thus addressing an underlying cause of age-related macular degeneration (AMD)
Through systematic evaluation utilizing report frequency and reporting odds ratio (ROR) metrics, the top 50 preferred terms (PTs) for each age group were identified and visualized (Supplementary Figs
Micro- and nanoplastics (MNPs) and their potential toxicological outcomes: State of science, knowledge gaps and research needs